The Impact of X-Chromosome Inactivation on Phenotypic Expression of X-Linked Neurodevelopmental Disorders
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Nearly 20% of genes located on the X chromosome are associated with neurodevelopmental disorders (NDD) due to their expression and role in brain functioning. Given their location, several of these genes are either subject to or can escape X-chromosome inactivation (XCI). The degree to which genes are subject to XCI can influence the NDD phenotype between males and females. We provide a general review of X-linked NDD genes in the context of XCI and detailed discussion of the sex-based differences related to MECP2 and FMR1, two common X-linked causes of NDD that are subject to XCI. Understanding the effects of XCI on phenotypic expression of NDD genes may guide the development of stratification biomarkers in X-linked disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studying XCI and escape genes in humans is methodologically challenging254 and difficult to relate to human brain tissues244, although catalogues of XCI across human tissues have helped identify genes contributing to sex-specific differences255.”
From Sex and gender in neurodevelopmental conditions (2023) · cites this paper as [244]
In the citing paper
“Evidence suggests that XCI skewing can cause phenotypic variability among female family members with FXS, but evidence regarding the role of XCI in the Rett syndrome phenotype is inconclusive244.”
From Sex and gender in neurodevelopmental conditions (2023) · cites this paper as [244]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
X-inactivation profile reveals extensive variability in X-linked gene expression in females
Carrel, L., & Willard, H. F. (2005) · Nature · doi:10.1038/nature03479 · Cited by 2,097
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources
Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M., Rajan, D., Vooren, S. V., Moreau, Y., Pettett, R. M., & Carter, N. P. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.010 · Cited by 1,990
Reversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230
Landscape of X chromosome inactivation across human tissues
GTEx Consortium, Tukiainen, T., Villani, A.-C., Yen, A., Rivas, M. A., Marshall, J. L., Satija, R., Aguirre, M., Gauthier, L., Fleharty, M., et al. (2017) · Nature · doi:10.1038/nature24265 · Cited by 1,138
The DNA sequence of the human X chromosome
Ross, M. T., Grafham, D. V., Coffey, A. J., Scherer, S., McLay, K., Muzny, D., Platzer, M., Howell, G. R., Burrows, C., Bird, C. P., et al. (2005) · Nature · doi:10.1038/nature03440 · Cited by 1,129
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system
Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S., & Heintz, N. (2012) · Cell · doi:10.1016/j.cell.2012.11.022 · Cited by 943
Online Mendelian Inheritance in Man 'OMIM'.
Amladi, S. (2003) · PubMed · Cited by 875
Van Esch, H., Bauters, M., Ignatius, J., Jansen, M., Raynaud, M., Hollanders, K., Lugtenberg, D., Bienvenu, T., Jensen, L. R., Gécz, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/444549 · Cited by 628
Association of FMR1 repeat size with ovarian dysfunction
Sullivan, A. K., Marcus, M., Epstein, M. P., Allen, E. G., Anido, A. E., Paquin, J. J., Yadav-Shah, M., & Sherman, S. L. (2005) · Human Reproduction · doi:10.1093/humrep/deh635 · Cited by 498
Co‐occurring conditions associated with FMR1 gene variations: Findings from a national parent survey
Bailey, D. B., Raspa, M., Olmsted, M., & Holiday, D. B. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32439 · Cited by 446
Epidemiology of fragile X syndrome: A systematic review and meta‐analysis
Hunter, J., Rivero‐Arias, O., Angelov, A., Kim, E., Fotheringham, I., & Leal, J. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36511 · Cited by 442
Haack, T. B., Hogarth, P., Kruer, M. C., Gregory, A., Wieland, T., Schwarzmayr, T., Graf, E., Sanford, L., Meyer, E., Kara, E., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.10.019 · Cited by 360
Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
Amir, R. E., Van Den Veyver, I. B., Schultz, R., Malicki, D. M., Tran, C. Q., Dahle, E. J., Philippi, A., Timar, L., Percy, A. K., Motil, K. J., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<670::aid-ana20>3.0.co;2-f · Cited by 352
MeCP2 binds to 5hmc enriched within active genes and accessible chromatin in the nervous system
Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S., & Heintz, N. (2013) · Epigenetics & Chromatin · doi:10.1186/1756-8935-6-s1-p52 · Cited by 345
FARZIN, F., PERRY, H., HESSL, D., LOESCH, D., COHEN, J., BACALMAN, S., GANE, L., TASSONE, F., HAGERMAN, P., & HAGERMAN, R. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604002-00012 · Cited by 325
The MECP2 duplication syndrome
Ramocki, M. B., Tavyev, Y. J., & Peters, S. U. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33184 · Cited by 300
Ramocki, M. B., Peters, S. U., Tavyev, Y. J., Zhang, F., Carvalho, C. M. B., Schaaf, C. P., Richman, R., Fang, P., Glaze, D. G., Lupski, J. R., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21715 · Cited by 299
Wolf, S. F., Jolly, D. J., Lunnen, K. D., Friedmann, T., & Migeon, B. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2806 · Cited by 298
Cheadle, J. P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.7.1119 · Cited by 288
Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia
Wang, X., Reid Sutton, V, Omar Peraza-Llanes, J., Yu, Z., Rosetta, R., Kou, Y.-C., Eble, T. N., Patel, A., Thaller, C., Fang, P., et al. (2007) · Nature Genetics · doi:10.1038/ng2057 · Cited by 285
Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia
Grzeschik, K.-H., Bornholdt, D., Oeffner, F., König, A., del Carmen Boente, M., Enders, H., Fritz, B., Hertl, M., Grasshoff, U., Höfling, K., et al. (2007) · Nature Genetics · doi:10.1038/ng2052 · Cited by 285
Gilfillan, G. D., Selmer, K. K., Roxrud, I., Smith, R., Kyllerman, M., Eiklid, K., Kroken, M., Mattingsdal, M., Egeland, T., Stenmark, H., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.013 · Cited by 232
MECP2 mutation in male patients with non‐specific X‐linked mental retardation
Orrico, A., Lam, C.-W., Galli, L., Dotti, M. T., Hayek, G., Tong, S.-F., Poon, P. M. K., Zappella, M., Federico, A., & Sorrentino, V. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01994-3 · Cited by 229
Mutations in PHF6 are associated with Börjeson–Forssman –Lehmann syndrome
Lower, K. M., Turner, G., Kerr, B. A., Mathews, K. D., Shaw, M. A., Gedeon, Á. K., Schelley, S., Hoyme, H. E., White, S. M., Delatycki, M. B., et al. (2002) · Nature Genetics · doi:10.1038/ng1040 · Cited by 217
Rett syndrome: clinical review and genetic update
Weaving, L. S., Ellaway, C. J., Gécz, J., & Christodoulou, J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.027730 · Cited by 213
X-linked diseases: susceptible females
Migeon, B. R. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0779-4 · Cited by 192
Laumonnier, F., Shoubridge, C., Antar, C., Nguyen, L. S., Esch, H. V., Kleefstra, T., Briault, S., Fryns, J. P., Hamel, B., Chelly, J., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.14 · Cited by 174
Zou, Y., Liu, Q., Chen, B., Zhang, X., Guo, C., Zhou, H., Li, J., Gao, G., Guo, Y., Yan, C., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/512489 · Cited by 161
Inoue, K., Osaka, H., Thurston, V. C., Clarke, J. T. R., Yoneyama, A., Rosenbarker, L., Bird, T. D., Hodes, M. E., Shaffer, L. G., & Lupski, J. R. (2002) · The American Journal of Human Genetics · doi:10.1086/342728 · Cited by 160
Seizures in Fragile X Syndrome: Characteristics and Comorbid Diagnoses
Berry-Kravis, E., Raspa, M., Loggin-Hester, L., Bishop, E., Holiday, D., & Bailey, D. B. (2010) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-115.6.461 · Cited by 155
The Role of Neuronal Complexes in Human X-Linked Brain Diseases
Laumonnier, F., Cuthbert, P. C., & Grant, S. G. N. (2007) · The American Journal of Human Genetics · doi:10.1086/511441 · Cited by 139
Human genes escaping X-inactivation revealed by single cell expression data
Wainer Katsir, K., & Linial, M. (2019) · BMC Genomics · doi:10.1186/s12864-019-5507-6 · Cited by 138
Fragile X analysis of 1112 prenatal samples from 1991 to 2010
Nolin, S. L., Glicksman, A., Ding, X., Ersalesi, N., Brown, W. T., Sherman, S. L., & Dobkin, C. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2815 · Cited by 136
Fragile X–associated tremor/ataxia syndrome in sisters related to X‐inactivation
Berry‐Kravis, E., Potanos, K. M., Weinberg, D., Zhou, L., & Goetz, C. G. (2004) · Annals of Neurology · doi:10.1002/ana.20360 · Cited by 135
O’Rawe, J. A., Wu, Y., Dörfel, M. J., Rope, A. F., Au, P. Y. B., Parboosingh, J. S., Moon, S., Kousi, M., Kosma, K., Smith, C. S., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.11.005 · Cited by 128
Nascimento, R. M. P., Otto, P. A., de Brouwer, A. P. M., & Vianna‐Morgante, A. M. (2006) · The American Journal of Human Genetics · doi:10.1086/507047 · Cited by 126
A mixed modality approach towards Xi reactivation for Rett syndrome and other X-linked disorders
Carrette, L. L. G., Wang, C., Wei, C., Press, W., Ma, W., Kelleher, R. J., & Lee, J. T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715124115 · Cited by 120
Effects of MECP2 mutation type, location and X‐inactivation in modulating Rett syndrome phenotype
Weaving, L. S., Williamson, S. L., Bennetts, B., Davis, M., Ellaway, C. J., Leonard, H., Thong, M., Delatycki, M., Thompson, E. M., Laing, N., et al. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10053 · Cited by 114
Kodera, H., Nakamura, K., Osaka, H., Maegaki, Y., Haginoya, K., Mizumoto, S., Kato, M., Okamoto, N., Iai, M., Kondo, Y., et al. (2013) · Human Mutation · doi:10.1002/humu.22446 · Cited by 110
Autism‐associated familial microdeletion of Xp11.22
Qiao, Y., Liu, X., Harvard, C., Hildebrand, M., Rajcan‐Separovic, E., Holden, J., & Lewis, M. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01028.x · Cited by 107
Fragile X syndrome: From protein function to therapy
Bagni, C., & Oostra, B. A. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36241 · Cited by 103
Viggiano, E., Ergoli, M., Picillo, E., & Politano, L. (2016) · Human Genetics · doi:10.1007/s00439-016-1666-6 · Cited by 96
Clinical features and X-inactivation in females heterozygous for creatine transporter defect
van de Kamp, J., Mancini, G., Pouwels, P., Betsalel, O., van Dooren, S., de Koning, I., Steenweg, M., Jakobs, C., van der Knaap, M., & Salomons, G. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01460.x · Cited by 88
THOC2 Mutations Implicate mRNA-Export Pathway in X-Linked Intellectual Disability
Kumar, R., Corbett, M. A., van Bon, B. W. M., Woenig, J. A., Weir, L., Douglas, E., Friend, K. L., Gardner, A. E., Shaw, M. A., Jolly, L. A., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.021 · Cited by 76
Harakalova, M., van den Boogaard, M.-J., Sinke, R., van Lieshout, S., van Tuil, M. C., Duran, K., Renkens, I., Terhal, P. A., de Kovel, C., Nijman, I. J., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100921 · Cited by 72
Nonsyndromic mental retardation and cryptogenic epilepsy in women with Doublecortin gene mutations
Guerrini, R., Moro, F., Andermann, E., Hughes, E., D’Agostino, D., Carrozzo, R., Bernasconi, A., Flinter, F. A., Parmeggiani, L., Volzone, A., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10588 · Cited by 71
Study, D., Palmer, E. E., Stuhlmann, T., Weinert, S., Haan, E., Van Esch, H., Holvoet, M., Boyle, J., Leffler, M., Raynaud, M., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.135 · Cited by 71
De novo MECP2 duplication in two females with random X-inactivation and moderate mental retardation
Grasshoff, U., von Bonin, M., Goehring, I., Ekici, A. B., Dufke, A., Cremer, K., Wagner, N., Rossier, E., Jauch, A. S., Walter, M. J., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.226 · Cited by 66
De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy
Lange, I., Helbig, K. L., Weckhuysen, S., Møller, R. S., Velinov, M. T., Dolzhanskaya, N., Marsh, E. D., Helbig, I., Devinsky, O., Tang, S., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103909 · Cited by 66
Synofzik, M., Hagen, J. M. V., Haack, T. B., Wilhelm, C., Lindig, T. M., Beck‐Wödl, S., Nabuurs, S. B., Kuilenburg, A. B. P., de Brouwer, A. P. M., & Schöls, L. J. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-24 · Cited by 65
Bijlsma, E. K., Collins, A. R., Papa, F. T., Tejada, M., Wheeler, P. G., Peeters, E. A. J., Gijsbers, A. C. J., van de Kamp, J. M., Kriek, M., Losekoot, M., et al. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.02.009 · Cited by 58
Heine‐Suñer, D., Torres‐Juan, L., Morlá, M., Busquets, X., Barceló, F., Picó, G., Bonilla, L. S., Govea, N., Bernués, M., & Rosell, J. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20160 · Cited by 56
Crawford, J., Lower, K. M., Hennekam, R. C. M., Van Esch, H., Mégarbané, A., Lynch, S. A., Turner, G., & Gécz, J. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033084 · Cited by 55
Analysis of X chromosome inactivation in autism spectrum disorders
Gong, X., Bacchelli, E., Blasi, F., Toma, C., Betancur, C., Chaste, P., Delorme, R., Durand, C. M., Fauchereau, F., Botros, H. G., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30688 · Cited by 54
X inactivation of the FMR1 fragile X mental retardation gene.
Kirchgessner, C. U., Warren, S. T., & Willard, H. F. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.925 · Cited by 52
Aberrant GRIA3 transcripts with multi‐exon duplications in a family with X‐linked mental retardation
Bonnet, C., Leheup, B., Béri, M., Philippe, C., Grégoire, M.-J., & Jonveaux, P. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32858 · Cited by 51
Santos-Rebouças, C. B., Belet, S., de Almeida, L. G., Ribeiro, M. G., Medina‐Acosta, E., Bahia, P. R. V., da Silva, A. F. A., dos Santos, F. L., de Lacerda, G. C. B., Pimentel, M. M. G., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.216 · Cited by 47
Õunap, K., Puusepp‐Benazzouz, H., Peters, M., Vaher, U., Rein, R., Proos, A., Field, M., & Reimand, T. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.01.004 · Cited by 47
PHF6 Deletions May Cause Borjeson-Forssman-Lehmann Syndrome in Females
Berland, S., Alme, K., Brendehaug, A., Houge, G., & Hovland, R. (2010) · Molecular Syndromology · doi:10.1159/000330111 · Cited by 44
Vianna, E. Q., Piergiorge, R. M., Gonçalves, A. P., dos Santos, J. M., Calassara, V., Rosenberg, C., Krepischi, A. C. V., da Silva, R. T. B., dos Santos, S. R., Ribeiro, M. G., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01981-8 · Cited by 44
Furtado, C. L. M., Luchiari, H. R., Pedroso, D. C. C., Kogure, G. S., Caetano, L. C., Santana, B. A., Santana, V. P., Benetti‐Pinto, C. L., dos Reis, F. M., Maciel, M. A., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.017 · Cited by 43
Zhao, Y., Zhang, X., Bao, X., Zhang, Q., Zhang, J., Cao, G., Zhang, J., Li, J., Wei, L., Pan, H., et al. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-24 · Cited by 41
X Chromosome Inactivation in Rett Syndrome and Its Correlations With MeCP2 Mutations and Phenotype
Bao, X., Jiang, S., Song, F., Pan, H., Li, M., & Wu, X.-R. (2008) · Journal of Child Neurology · doi:10.1177/0883073807307077 · Cited by 39
De novo loss-of-function variants in X-linked MED12 are associated with Hardikar syndrome in females
Li, D., Strong, A., Shen, K. M., Cassiman, D. M., Dyck, M. V., Linhares, N. D., Valadares, E. R., Wang, T.-C., Pena, S. D. J., Jaeken, J., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-01031-7 · Cited by 39
Woodward, K. J., Kirtland, K. A., Dlouhy, S. R., Raskind, W. H., Bird, T. D., Malcolm, S., & Abeliovich, D. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200480 · Cited by 38
Mignon‐Ravix, C., Cacciagli, P., Choucair, N., Popovici, C., Missirian, C., Milh, M., Mégarbané, A., Busa, T., Julia, S., Girard, N. J., et al. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36602 · Cited by 36
Frints, S. G. M., Ozantürk, A., Criado, G. R., Grasshoff, U., de Hoon, B., Field, M. J., Manouvrier‐Hanu, S., Hickey, S. E., Kammoun, M., Gripp, K. W., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0065-x · Cited by 35
Spath, M. A., Nillesen, W. M., Smits, A. P. T., Feuth, T. B., Braat, D. D. M., van Kessel, A. G., & Yntema, H. G. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33243 · Cited by 34
Rodríguez‐Revenga, L., Madrigal, I., Bádenas, C., Xunclà, M., Jiménez, L., & Milà, M. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181a06a37 · Cited by 33
MAOA and GYG2 are submitted to X chromosome inactivation in human fibroblasts
Stabellini, R., de Mello, J. C. M., Hernandes, L. M., & Pereira, L. V. (2009) · Epigenetics · doi:10.4161/epi.4.6.9492 · Cited by 32
Salsano, E., Tabano, S., Sirchia, S. M., Colapietro, P., Castellotti, B., Gellera, C., Rimoldi, M., Pensato, V., Mariotti, C., Pareyson, D., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-10 · Cited by 32
Vincent, A. K., Noor, A., Janson, A., Minassian, B., Ayub, M., Vincent, J., & Morel, C. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01812.x · Cited by 32
X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
Hall, D. A., Robertson-Dick, E. E., O’Keefe, J. A., Hadd, A. G., Zhou, L., & Berry‐Kravis, E. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000045 · Cited by 32
Badens, C., Martini, N., Courrier, S., Portes, V. D., Touraine, R. L., Lévy, N., & Edery, P. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31400 · Cited by 29
X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body
Stichelen, S. O.-V., & Hanover, J. A. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00256 · Cited by 29
Martínez, R. V., Bonilla, V., Jiménez, A., Lucas, M., Vega, C., Ramos, I., Sobrino, F., & Pintado, E. (2005) · Molecular Diagnosis · doi:10.1007/bf03260084 · Cited by 28
Xiol, C., Vidal, S., Pascual‐Alonso, A., Blasco, L. C., Brandi, N., Pacheco, P., Gerotina, E., O’Callaghan, M., Pineda, M., Armstrong, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48385-w · Cited by 28
MECP2duplication: Possible cause of severe phenotype in females
Schwoerer, J. S., Laffin, J. J. S., Haun, J. M., Raca, G., Friez, M. J., & Giampietro, P. F. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36380 · Cited by 27
Familial cases and male cases with MECP2 mutations
Zhang, Q., Zhao, Y., Bao, X., Luo, J. J., Zhang, X., Li, J., Wei, L., & Wu, X. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32534 · Cited by 27
Hamici, S., Bastaki, F., & Khalifa, M. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.07.014 · Cited by 27
Wada, T., Sugie, H., Fukushima, Y., & Saitoh, S. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30901 · Cited by 26
Microphthalmia with Linear Skin Defects Syndrome
García-Rabasco, A. E., De‐Unamuno, B., Martı́nez, F., Febrer‐Bosch, I., & Alegre‐de‐Miquel, V. (2012) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2012.01735.x · Cited by 26
Myers, G. F., Mazzocco, M. M. M., Maddalena, A., & Reiss, A. L. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200112000-00001 · Cited by 26
Seto, T., Hamazaki, T., Nishigaki, S., Kudo, S., Shintaku, H., Ondo, Y., Shimojima, K. Y., & Yamamoto, T. (2017) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2017.01031 · Cited by 25
Wang, Z., Yan, A., Lin, Y., Xie, H., Zhou, C., & Lan, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057977 · Cited by 22
Lambert, N., Dauve, C., Ranza, E., Makrythanasis, P., Santoni, F. A., Béna, F., Gimelli, S., Blouin, J., Guipponi, M., Bottani, A., et al. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0459-2 · Cited by 21
Cognitive function in Coffin–Lowry syndrome
Simensen, R. J., Abidi, F., Collins, J., Schwartz, C., & Stevenson, R. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.610410.x · Cited by 20
Schirwani, S., Novelli, A., Digilio, M. C., Bourn, D., Wilson, V., Roberts, C., Dallapiccola, B., & Hobson, E. (2018) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2018.07.022 · Cited by 20
Polla, D. L., Saunders, H. R., Vries, B. B. A. D., van Bokhoven, H., & de Brouwer, A. P. M. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.861 · Cited by 20
Differential phenotypic expression of a novel PDHA1 mutation in a female monozygotic twin pair
Horga, A., Woodward, C. E., Mills, A., Pareés, I., Hargreaves, I. P., Brown, R. M., Bugiardini, E., Brooks, T., Manole, A., Remzova, E., et al. (2019) · Human Genetics · doi:10.1007/s00439-019-02075-9 · Cited by 20
Skewed X‐inactivation in a family with DLG3‐associated X‐linked intellectual disability
Gieldon, L., Mackenroth, L., Betcheva‐Krajcir, E., Rump, A., Beck‐Wödl, S., Schallner, J., Donato, N. D., Schröck, E., & Tzschach, A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38348 · Cited by 17
Cerebellar ataxia, neuropathy, hearing loss, and intellectual disability due to AIFM1 mutation
Pandolfo, M., Rai, M., Remiche, G., Desmyter, L., & Vandernoot, I. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000420 · Cited by 17
Conti, V., Marini, C., Gana, S., Sudi, J., Dobyns, W. B., & Guerrini, R. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33923 · Cited by 16
Álvarez‐Mora, M. I., Rodríguez‐Revenga, L., Feliu, A., Bádenas, C., Madrigal, I., & Milà, M. (2015) · Neurodegenerative Diseases · doi:10.1159/000441566 · Cited by 16
Microphthalmia with linear skin defects syndrome
INSERM (2020) · Definitions · doi:10.32388/6l7a9l · Cited by 16
Renda, M. M., Voigt, R. G., Babovic‐Vuksanovic, D., Highsmith, W. E., Vinson, S. S., Sadowski, C. M., & Hagerman, R. J. (2012) · Journal of Child Neurology · doi:10.1177/0883073812469723 · Cited by 15
Skewed X‐inactivation in a family with mental retardation and PQBP1 gene mutation
Fichera, M., Falco, M., Giudice, M. L., Castiglia, L., Guarnaccia, V., Calı̀, F., Spalletta, A., Scuderi, C., & Avola, E. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00436.x · Cited by 13
Li, X., Xie, H., Chen, Q., Yu, X., Yi, Z., Li, E., Zhang, T., Wang, J., Zhong, J., & Chen, X. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0486-4 · Cited by 13
Linkage studies in carriers of Lowe oculo-cerebro-renal syndrome.
Hittner, H. M., Carroll, A. J., & Prchal, J. T. (1982) · PubMed · Cited by 12
Johnston-MacAnanny, E. B., Koty, P. P., Pettenati, M. J., Brady, M., Yalcinkaya, T. M., & Schmidt, D. W. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.039 · Cited by 11
Wayhelová, M., Ryzí, M., Oppelt, J., Hladílková, E., Vallová, V., Krsková, L., Vilémová, M., Polackova, H., Gaillyová, R., & Kuglík, P. (2020) · Neurogenetics · doi:10.1007/s10048-020-00616-3 · Cited by 11
Renpenning syndrome in a female
Cho, R. Y., Peñaherrera, M. S., du Souich, C., Huang, L., Mwenifumbo, J. C., Nelson, T. N., Elliott, A. M., Adam, S., Study, C., Eydoux, P., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61451 · Cited by 10
Translational Medicine Strategies in Drug Development for Neurodevelopmental Disorders
Srivastava, S., Şahin, M., & Prock, L. A. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00022-9 · Cited by 9
Martorell, L., Nascimento, M. T., Roura, R. C., Genovès, J., Naudó, M., & Nascimento, A. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.140 · Cited by 8
Novel clinical and genetic insight into CXorf56-associated intellectual disability
Rocha, M. E., Silveira, T. R. D., Sasaki, E., Sás, D. M., Lourenço, C. M., Kandaswamy, K. K., Beetz, C., Rolfs, A., Bauer, P., Reardon, W., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0558-3 · Cited by 8
The Clinical Phenotype of the Fragile X Syndrome and Related Disorders
Neri, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00001-9 · Cited by 6
Iijima, T., Hayami, N., Takaichi, K., Morisada, N., Nozu, K., Iijima, K., Sawa, N., Hoshino, J., & Ubara, Y. (2019) · Internal Medicine · doi:10.2169/internalmedicine.2571-18 · Cited by 5
Ghesh, L., Besnard, T., Nizon, M., Trochu, E., Landeau‐Trottier, G., Bréhéret, F., Thauvin‐Robinet, C., Bruel, A., Kuentz, P., Coubes, C., et al. (2021) · Human Mutation · doi:10.1002/humu.24188 · Cited by 2
Cited by
Sex and gender in neurodevelopmental conditions
Bölte, S., Neufeld, J., Marschik, P. B., Williams, Z. J., Gallagher, L., & Lai, M.-C. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00774-6 · Cited by 249
Li, J., Ming, Z., Yang, L., Wang, T., Liu, G., & Ma, Q. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.04.007 · Cited by 92
Canton, A. P. M., Tinano, F. R., Guasti, L., Montenegro, L. R., Ryan, F., Shears, D. J., de Melo, M. E., Gomes, L. G., Piana, M. P., Brauner, R., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00131-6 · Cited by 35
“Most human X-linked genes are subject to X-inactivation in females, a mechanism that ensures dosage compensation between both sexes (5, 8).”
BackgroundAuditory Dysfunction in Animal Models of Autism Spectrum Disorder
Castro, A. C., & Monteiro, P. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.845155 · Cited by 34
A novel quantitative targeted analysis of X-chromosome inactivation (XCI) using nanopore sequencing
Johansson, J., Lidéus, S., Höijer, I., Ameur, A., Gudmundsson, S., Annerén, G., Bondeson, M.-L., & Wilbe, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-34413-3 · Cited by 22
“Secondly, expression of the pathogenic allele may lead to manifestation of phenotypes in carrier females of X-linked traits 19–28 and can explain phenotypic differences observed in affected carrier females and individuals with X-aneuploidies 21,24,29–36 .”
Background
Metadata
- Authors
- Brand, B. A., Blesson, A. E., & Smith-Hicks, C. L.
- Affiliations
- Kennedy Krieger Institute (US)
- Department of Neurology and Developmental Medicine, Kennedy Krieger Institute, Baltimore, MD 21205, USA
- ORCID
- Blesson, Alyssa E
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2021-07-09
- Volume
- 11
- Issue
- 7
- Pages
- 904
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC8305405
- OpenAlex
- W3180808699
- Cited by
- 39
- References
- 108
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 5 · 2023: 10 · 2022: 6
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- X chromosome inactivation, X-linked neurodevelopmental disorder, sex differences in phenotype, MeCP2, FMR1 gene, X-inactivation escape, X-linked disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
